Clinical Trial

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

Study acronym: LINC6
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-05-16; most recent amendment 2025-11-19.
Status change: Recruiting → Active, Not Recruiting 2024-07-12
Status change: Not Yet Recruiting → Recruiting 2023-08-18
Trial Details
NCT Number NCT05382156
Lead Sponsor RECORDATI GROUP
Conditions Endogenous Cushing's Syndrome
Enrollment 206 participants
Start Date 2022-06-13
Primary Completion 2027-06 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-20